| Quarterly Financials | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 1,566 | 1,576 | 1,918 | 1,839 | 1,797 | 1,853 | 2,156 | 2,209 | 2,032 | 2,091 | 2,326 | 2,307 | 1,768 | 2,252 | 2,234 | 2,421 | 2,381 | 2,515 | 2,662 | 2,750 | 2,699 | 2,835 | 3,202 | 956 | 849 | 933 | 1,108 | 978 | 6,122 | 1,122 | 1,083 | 1,032 | 1,111 | 1,226 | 1,214 |
| Expenses | 1,517 | 1,428 | 1,643 | 1,521 | 1,651 | 1,714 | 1,891 | 1,851 | 1,806 | 1,842 | 1,955 | 1,878 | 1,618 | 1,972 | 1,900 | 2,070 | 2,091 | 2,162 | 2,253 | 2,267 | 2,370 | 2,498 | 2,744 | 687 | 747 | 856 | 806 | 861 | 841 | 869 | 888 | 845 | 881 | 962 | 1,012 |
| EBITDA | 49 | 148 | 276 | 318 | 146 | 139 | 265 | 358 | 226 | 249 | 371 | 429 | 150 | 280 | 335 | 351 | 290 | 353 | 409 | 482 | 329 | 337 | 458 | 269 | 102 | 78 | 302 | 117 | 5,281 | 252 | 195 | 187 | 230 | 264 | 202 |
| Operating Profit % | 3 % | 9 % | 9 % | 15 % | 7 % | 7 % | 12 % | 16 % | 11 % | 12 % | 16 % | 18 % | 8 % | 12 % | 15 % | 13 % | 12 % | 14 % | 15 % | 17 % | 11 % | 11 % | 14 % | 15 % | 11 % | 8 % | 16 % | 12 % | 16 % | 20 % | 15 % | 16 % | 18 % | 20 % | 15 % |
| Depreciation | 79 | 95 | 68 | 56 | 74 | 76 | 79 | 78 | 126 | 149 | 140 | 171 | 155 | 153 | 157 | 153 | 153 | 156 | 161 | 170 | 175 | 189 | 198 | 54 | 51 | 54 | 57 | 58 | 60 | 62 | 62 | 64 | 63 | 66 | 68 |
| Interest | 43 | 46 | 49 | 47 | 40 | 40 | 56 | 55 | 88 | 88 | 72 | 112 | 80 | 75 | 62 | 77 | 67 | 61 | 67 | 62 | 69 | 77 | 87 | 25 | 25 | 30 | 25 | 30 | 29 | 32 | 31 | 32 | 31 | 31 | 32 |
| Profit Before Tax | -73 | 7 | 158 | 216 | 32 | 24 | 130 | 224 | 12 | 12 | 160 | 146 | -85 | 53 | 115 | 122 | 71 | 135 | 181 | 250 | 85 | 71 | 173 | 190 | 26 | -7 | 221 | 28 | 5,191 | 159 | 102 | 91 | 136 | 167 | 103 |
| Tax | 7 | 9 | -1 | 10 | 12 | 10 | 17 | 4 | 2 | 5 | 8 | -0 | 4 | 10 | 8 | 5 | 11 | 8 | 13 | 4 | 6 | 17 | 14 | 7 | 6 | 8 | 11 | 31 | 39 | 53 | 38 | 5 | 43 | 46 | 44 |
| Net Profit | -80 | -3 | 159 | 205 | 20 | 14 | 113 | 220 | 10 | 7 | 151 | 146 | -89 | 42 | 107 | 117 | 60 | 128 | 168 | 246 | 80 | 54 | 159 | 183 | 20 | -15 | 209 | -2 | 5,152 | 106 | 64 | 86 | 94 | 121 | 59 |
| EPS in ₹ | -1.66 | 0.01 | 3.33 | 4.07 | 0.25 | 0.22 | 2.00 | 4.10 | 0.06 | 0.06 | 2.78 | 2.61 | -1.67 | 0.66 | 1.86 | 2.12 | 0.89 | 2.15 | 2.98 | 4.55 | 1.38 | 0.93 | 2.80 | 3.43 | 0.10 | -0.62 | 3.60 | -0.48 | 103.34 | 1.94 | 1.14 | 1.59 | 1.67 | 2.13 | 1.02 |
Aster DM Healthcare
Aster DM Healthcare
534.90
-5.45
(-1.01%)
Market Cap
27,714.29 Cr
PE Ratio
77.93
Volume
5,91,616.00
Day High - Low
540.30 - 528.90
52W High-Low
732.20 - 387.10
There are 2 new updates from the company18 hrs ago
View
Key Fundamentals
Market Cap
27,714.29 Cr
EPS
107.98
PE Ratio
77.93
PB Ratio
6.69
Book Value
80.76
EBITDA
912.80
Dividend Yield
0.89 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
9.22
Debt to Equity
0.47
Analyst Rating and Forecast
- By Refinitiv from9 analysts
Actual
Company News
View All News
Aster DM Healthcare reports Q3FY26 results with revenue of ₹665.75 crores. Board approves ESOP Scheme 2026, loan conversion of ₹129.35 crores, and merger proceedings with Quality Care India Limited.
Aster DM Healthcare's Investment Committee approved acquisition of additional equity shares in material subsidiary MIMS to increase shareholding from 79.75% to 100% through cash consideration of INR 202 per share.
Aster DM Healthcare schedules earnings conference call for February 02, 2026 at 11:00 AM IST to discuss Q3FY26 financial results for quarter ended December 31, 2025.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
7,108.50 | #1 1,02,209.32 | 59.17 | #1 21,994.30 | 14.76 | #1 1,505 | 24.84 | 54.02 | |
1,031.95 | 1,00,384.93 | 73.57 | 7,184.10 | #1 28.65 | 1,076 | #1 74.34 | 53.38 | |
856.05 | 64,628.19 | 62.54 | 7,849.70 | 13.25 | 809 | 70.27 | 45.99 | |
1,732.00 | 35,395.29 | #1 42.57 | 5,575.00 | 12.29 | 790 | 30.03 | 41.16 | |
1,102.50 | 29,634.14 | 53.68 | 3,771.40 | 12.59 | 481 | -33.52 | 49.96 | |
534.90 | #6 27,714.29 | #8 77.93 | #5 4,286.70 | #6 15.12 | #7 337 | #7 -8.85 | 35.37 | |
605.15 | 24,214.41 | 68.57 | 3,067.00 | 21.98 | 415 | -40.35 | 47.24 | |
455.45 | 14,413.63 | 88.83 | 1,757.00 | 27.64 | 110 | 54.61 | 39.22 | |
1,120.50 | 11,379.70 | 43.87 | 1,566.90 | 17.46 | 244 | 7.26 | 22.35 | |
597.65 | 8,427.32 | 208.44 | 2,257.70 | 17.03 | 49 | 0.00 | 40.73 |
Growth Rate
Revenue Growth
15.12 %
Net Income Growth
64.48 %
Cash Flow Change
169.34 %
ROE
126.54 %
ROCE
87.55 %
EBITDA Margin (Avg.)
31.50 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 | 6,606 |
| Fixed Assets | 3,520 | 3,738 | 4,289 | 7,124 | 6,749 | 7,009 | 9,052 | 3,175 | 3,920 |
| Current Assets | 2,473 | 2,869 | 3,617 | 4,096 | 3,629 | 4,097 | 4,922 | 14,165 | 1,902 |
| Capital Work in Progress | 290 | 402 | 550 | 736 | 934 | 998 | 279 | 170 | 293 |
| Investments | 32 | 38 | 22 | 34 | 63 | 45 | 80 | 17 | 245 |
| Other Assets | 2,966 | 3,307 | 4,076 | 4,544 | 3,898 | 4,495 | 5,470 | 14,629 | 2,148 |
| Total Liabilities | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 | 6,606 |
| Current Liabilities | 2,201 | 2,224 | 2,668 | 3,722 | 3,196 | 3,559 | 4,655 | 11,288 | 879 |
| Non Current Liabilities | 2,355 | 2,071 | 2,589 | 4,997 | 4,614 | 4,505 | 5,366 | 1,673 | 2,076 |
| Total Equity | 2,251 | 3,190 | 3,680 | 3,719 | 3,834 | 4,483 | 4,861 | 5,030 | 3,651 |
| Reserve & Surplus | 1,034 | 1,953 | 2,334 | 2,401 | 2,501 | 3,080 | 3,574 | 3,686 | 2,554 |
| Share Capital | 403 | 505 | 505 | 497 | 497 | 500 | 500 | 500 | 500 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 5 | -122 | 61 | 33 | -110 | 120 | 65 | 66 | 332 | 82 |
| Investing Activities | -439 | -775 | -1,136 | -522 | -702 | -658 | -333 | -563 | -951 | -878 | 6,015 |
| Operating Activities | 236 | 203 | 361 | 537 | 601 | 1,223 | 1,569 | 1,314 | 1,834 | 158 | 425 |
| Financing Activities | 203 | 578 | 654 | 46 | 134 | -675 | -1,116 | -686 | -817 | 1,053 | -6,358 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Apr 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.89 % | 40.38 % | 40.39 % | 40.39 % | 40.39 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 33.09 % | 29.09 % | 29.09 % | 40.21 % | 29.09 % | 33.48 % | 27.08 % | 23.85 % | 22.62 % | 21.66 % | 11.86 % | 19.64 % | 18.72 % | 18.46 % |
| DIIs | 7.81 % | 8.73 % | 7.78 % | 7.87 % | 8.12 % | 9.62 % | 8.94 % | 8.93 % | 8.94 % | 8.56 % | 7.64 % | 7.15 % | 13.70 % | 16.35 % | 20.91 % | 22.91 % | 24.59 % | 24.09 % | 25.28 % | 26.32 % | 26.12 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 3.70 % | 4.44 % | 4.21 % | 4.33 % | 3.92 % | 3.70 % | 3.43 % | 3.34 % | 3.18 % | 3.39 % | 3.15 % | 2.96 % | 3.09 % | 6.98 % | 5.94 % | 5.04 % | 4.38 % | 4.12 % | 3.94 % | 3.86 % | 4.07 % |
| Others | 50.61 % | 48.94 % | 50.12 % | 49.92 % | 50.08 % | 48.80 % | 49.75 % | 16.76 % | 16.92 % | 17.08 % | 7.11 % | 18.93 % | 7.85 % | 7.72 % | 7.42 % | 7.55 % | 7.49 % | 19.56 % | 10.76 % | 10.70 % | 10.95 % |
| No of Share Holders | 0 | 78,719 | 93,506 | 87,804 | 80,746 | 80,427 | 78,374 | 80,913 | 82,129 | 71,379 | 67,673 | 67,331 | 80,931 | 2,06,660 | 1,74,171 | 1,59,038 | 1,54,014 | 1,51,664 | 1,48,139 | 1,47,304 | 1,46,998 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 120 | 5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.82 | 0.93 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 31 Aug 2023 |  Annual General Meeting | NA | 31 Aug 2023 | 312.45 | 331.20 |
| 23 Apr 2024 |  Dividend | ₹ 118.00 /share | 23 Apr 2024 | 475.25 | 513.35 |
| 22 Aug 2024 | Dividend | ₹ 2.00 /share | 22 Aug 2024 | 375.20 | 401.15 |
| 29 Aug 2024 | Annual General Meeting | NA | 29 Aug 2024 | 379.30 | 409.90 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 427.95 | 405.20 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 494.65 | 485.30 |
| 10 Feb 2025 | Dividend | ₹ 4.00 /share | 10 Feb 2025 | 485.30 | 473.20 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 550.10 | 584.15 |
| 30 Jul 2025 | Quarterly Result Announcement | NA | 30 Jul 2025 | 595.05 | 590.95 |
| 28 Aug 2025 | Dividend | ₹ 1.00 /share | 28 Aug 2025 | 584.15 | 601.00 |
| 04 Sept 2025 | Annual General Meeting | NA | 04 Sept 2025 | 590.95 | 620.00 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 697.60 | 688.70 |
| 30 Jan 2026 | Quarterly Result Announcement | NA | 30 Jan 2026 | 576.00 | 539.15 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 hr ago
1 hr agoAnnouncement under Regulation 30 (LODR)-Investor Presentation4 hrs ago
4 hrs agoNotice Of Meeting Of The Unsecured Creditors Of Aster DM Healthcare Limited To Be Convened As Per The Directions Provided In The Order Of The Honble NCLT Hyderabad18 hrs ago
18 hrs agoNotice Of Meeting Of The Equity Shareholders Of Aster DM Healthcare Limited To Be Convened As Per The Directions Provided In The Order Of The Honble NCLT Hyderabad18 hrs ago
18 hrs agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Change in Management5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
5 days agoUpdates5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Acquisition5 days ago
5 days agoBoard Meeting Outcome for Outcome Of Board Meeting5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Acquisition7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoBoard Meeting Intimation for Approving Unaudited Financial Results For The Quarter Ended December 31 2025Jan 23, 2026
Jan 23, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 23, 2026
Jan 23, 2026Receipt Of NCLT Order Dated January 21 2026Jan 22, 2026
Jan 22, 2026Monthly Report On Special Window Re-Lodgement Of SharesJan 07, 2026
Jan 07, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 03, 2026
Jan 03, 2026Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 31, 2025
Dec 31, 2025Closure of Trading WindowDec 29, 2025
Dec 29, 2025Clarification Regarding Media ReleaseDec 20, 2025
Dec 20, 2025Monthly Report On Special Window For Re-Lodgement Of SharesDec 08, 2025
Dec 08, 2025Monthly Report On Special Window For Re-Lodgement Of SharesDec 08, 2025
Dec 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 03, 2025
Dec 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 23, 2025
Nov 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 23, 2025
Nov 23, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 19, 2025
Nov 19, 2025Receipt Of RD Order For Change In The Registered Office And Consequent Alteration Of Memorandum Of Association Of The CompanyNov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Nov 14, 2025Monthly Report On Special Window Re-Lodgement Of SharesNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-CessationNov 09, 2025
Nov 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 06, 2025
Nov 06, 2025Results - Financial Results For Sep 30 2025Nov 06, 2025
Nov 06, 2025Board Meeting Outcome for Outcome Of Board MeetingNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 03, 2025
Nov 03, 2025Board Meeting Intimation for Quarterly Results And Other MattersOct 31, 2025
Oct 31, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Monthly Report On Special Window Re-Lodgment Of SharesOct 09, 2025
Oct 09, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementOct 06, 2025
Oct 06, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 35.37
ATR(14)
Volatile 23.44
STOCH(9,6)
Neutral 37.64
STOCH RSI(14)
Neutral 66.45
MACD(12,26)
Bearish -0.99
ADX(14)
Strong Trend 34.99
UO(9)
Bearish 49.00
ROC(12)
Downtrend And Accelerating -5.70
WillR(14)
Neutral -75.87
About Aster DM Healthcare
Aster DM Healthcare is a healthcare service provider operating in the GCC and India. Founded in 1987 by Dr. Azad Moopen, the company offers a range of healthcare services through a network of hospitals, clinics, pharmacies, and labs. As of March 2023, Aster DM Healthcare operates 32 hospitals, 127 clinics,...more
Listing Date
26 Feb, 2018(7 Years,
10 days)
Chairperson NameMandayapurath Azad Moopen
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
